Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma.
基质金属蛋白酶 2 血浆水平与接受贝伐单抗治疗的复发性高级别胶质瘤患者的疗效和生存率的关系
期刊:Neuro-Oncology
影响因子:13.4
doi:10.1093/neuonc/not226
Tabouret Emeline, Boudouresque Françoise, Barrie Maryline, Matta Mona, Boucard Celine, Loundou Anderson, Carpentier Antoine, Sanson Marc, Metellus Philippe, Figarella-Branger Dominique, Ouafik L'houcine, Chinot Olivier
